Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

Janus kinase (JAK) inhibitors can quickly and effectively manage ulcerative colitis (UC), especially when more conventional treatments haven’t worked. UC is a type of inflammatory bowel disease ...

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.

Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.